Vir Biotechnology, Inc. (VIR)

9.09 -0.23 (-2.47%) USD  |  NASDAQ  |  Feb 27, 16:00
8.73 -0.36 (-3.96%) After-Hours: 04:59
More

Vir Biotechnology Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Hims & Hers Health, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Xeris Biopharma Holdings, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Sensei Biotherapeutics, Inc. Upgrade